ModelEdge

InMed Pharmaceuticals Inc.

Filing Type	425
Filing Date	5/18/2026
Updated	5/19/26, 8:34 AM

Filing

Earnings Release

Exhibits

425Prospectus Filed Pursuant to Rule 425

EX-2.1AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF MAY 19, 2026, BY AND AMONG INMED PHARMACEUTICALS INC., INDIGO MERGER SUB CORP., INDIGO MERGER SUB II, LLC AND MENTARI THERAPEUTICS, INC

EX-10.1FORM OF SHAREHOLDER SUPPORT AGREEMENT

EX-10.2FORM OF STOCKHOLDER SUPPORT AGREEMENT

EX-10.3FORM OF LOCK-UP AGREEMENT

EX-10.4FORM OF CVR AGREEMENT

EX-10.5FORM OF MENTARI SECURITIES PURCHASE AGREEMENT

EX-99.1PRESS RELEASE, ISSUED ON MAY 19, 2026

EX-99.2INVESTOR PRESENTATION, DATED MAY 2026

EX-99.3CONFERENCE CALL TRANSCRIPT DATED MAY 19, 2026